246 related articles for article (PubMed ID: 34475178)
1. 'Slash and clear' vector control for onchocerciasis elimination and epilepsy prevention: a protocol of a cluster randomised trial in Cameroonian villages.
Siewe Fodjo JN; Vieri MK; Ngarka L; Njamnshi WY; Nfor LN; Mengnjo MK; Hendy A; Enyong PA; Palmer D; Basanez MG; Colebunders R; Njamnshi AK
BMJ Open; 2021 Sep; 11(9):e050341. PubMed ID: 34475178
[TBL] [Abstract][Full Text] [Related]
2. Onchocerciasis in the Ntui Health District of Cameroon: epidemiological, entomological and parasitological findings in relation to elimination prospects.
Siewe Fodjo JN; Ngarka L; Njamnshi WY; Enyong PA; Zoung-Kanyi Bissek AC; Njamnshi AK
Parasit Vectors; 2022 Nov; 15(1):444. PubMed ID: 36443885
[TBL] [Abstract][Full Text] [Related]
3. The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol.
Abd-Elfarag G; Logora MY; Carter JY; Ojok M; Songok J; Menon S; Wit F; Lako R; Colebunders R
Infect Dis Poverty; 2018 Nov; 7(1):112. PubMed ID: 30424817
[TBL] [Abstract][Full Text] [Related]
4. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
Wanji S; Nji TM; Hamill L; Dean L; Ozano K; Njouendou AJ; Abong RA; Obie ED; Amuam A; Ekanya R; Ndongmo WPC; Ndzeshang BL; Fung EG; Nnamdi DB; Nkimbeng DA; Teghen S; Kah E; Piotrowski H; Forrer A; Khan JAM; Woode ME; Niessen L; Watson V; Njoumemi Z; Murdoch ME; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
Parasit Vectors; 2019 Dec; 12(1):574. PubMed ID: 31801631
[TBL] [Abstract][Full Text] [Related]
5. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.
Siewe Fodjo JN; Tatah G; Tabah EN; Ngarka L; Nfor LN; Chokote SE; Mengnjo MK; Dema F; Sitouok AT; Nkoro G; Ntone FE; Bissek AZ; Chesnais CB; Boussinesq M; Colebunders R; Njamnshi AK
Infect Dis Poverty; 2018 Dec; 7(1):114. PubMed ID: 30501640
[TBL] [Abstract][Full Text] [Related]
7. Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years.
Greter H; Mmbando B; Makunde W; Mnacho M; Matuja W; Kakorozya A; Suykerbuyk P; Colebunders R
BMJ Open; 2018 Mar; 8(3):e017188. PubMed ID: 29605818
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.
Mmbando BP; Suykerbuyk P; Mnacho M; Kakorozya A; Matuja W; Hendy A; Greter H; Makunde WH; Colebunders R
Infect Dis Poverty; 2018 Jun; 7(1):64. PubMed ID: 29921319
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of epilepsy and relationship with onchocerciasis prevalence in villages of the Ntui Health District of Cameroon.
Ngarka L; Siewe Fodjo JN; Ambomatei C; Njamnshi WY; Taryunyu Njamnshi JN; Nfor LN; Mengnjo MK; Njamnshi AK
Epilepsy Behav; 2023 May; 142():109184. PubMed ID: 36972641
[TBL] [Abstract][Full Text] [Related]
10. Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon.
Forrer A; Wanji S; Obie ED; Nji TM; Hamill L; Ozano K; Piotrowski H; Dean L; Njouendou AJ; Ekanya R; Ndongmo WPC; Fung EG; Nnamdi DB; Abong RA; Beng AA; Eyong ME; Ndzeshang BL; Nkimbeng DA; Teghen S; Suireng A; Ashu EE; Kah E; Murdoch MM; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33431378
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria.
Siewe JNF; Ukaga CN; Nwazor EO; Nwoke MO; Nwokeji MC; Onuoha BC; Nwanjor SO; Okeke J; Osahor K; Chimechefulam L; Ogomaka AI; Amaechi AA; Ezenwa CI; Ezike MN; Ikpeama C; Nwachukwu O; Eriama-Joseph AI; Nwoke BEB; Colebunders R
Infect Dis Poverty; 2019 Jan; 8(1):8. PubMed ID: 30670093
[TBL] [Abstract][Full Text] [Related]
12. Important progress towards elimination of onchocerciasis in the West Region of Cameroon.
Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
Parasit Vectors; 2017 Aug; 10(1):373. PubMed ID: 28774318
[TBL] [Abstract][Full Text] [Related]
13. Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study.
Bhwana D; Amaral LJ; Mhina A; Hayuma PM; Francis F; Siewe Fodjo JN; Mmbando BP; Colebunders R
PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011178. PubMed ID: 37379350
[TBL] [Abstract][Full Text] [Related]
14. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
Abegunde AT; Ahuja RM; Okafor NJ
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures.
Gumisiriza N; Mubiru F; Siewe Fodjo JN; Mbonye Kayitale M; Hotterbeekx A; Idro R; Makumbi I; Lakwo T; Opar B; Kaducu J; Wamala JF; Colebunders R
Infect Dis Poverty; 2020 Mar; 9(1):12. PubMed ID: 32114979
[TBL] [Abstract][Full Text] [Related]
16. Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment.
Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Mbigha-Ghogomu S; Souopgui J; Zoure HG; Boussinesq M; Kamgno J; Robert A
Parasit Vectors; 2016 Nov; 9(1):581. PubMed ID: 27842567
[TBL] [Abstract][Full Text] [Related]
17. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
[TBL] [Abstract][Full Text] [Related]
18. Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
Colebunders R; Kaiser C; Basáñez MG; Olliaro P; Lakwo T; Siewe Fodjo JN
Int J Infect Dis; 2022 Mar; 116():302-305. PubMed ID: 35074518
[TBL] [Abstract][Full Text] [Related]
19. Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon.
Boullé C; Njamnshi AK; Dema F; Mengnjo MK; Siewe Fodjo JN; Bissek AZ; Suykerbuyk P; Lenou-Nanga CG; Nana-Djeunga HC; Kamgno J; Chesnais CB; Boussinesq M; Colebunders R
Parasit Vectors; 2019 Mar; 12(1):114. PubMed ID: 30890155
[TBL] [Abstract][Full Text] [Related]
20. The blackfly vectors and transmission of Onchocerca volvulus in Mahenge, south eastern Tanzania.
Hendy A; Krüger A; Pfarr K; De Witte J; Kibweja A; Mwingira U; Dujardin JC; Post R; Colebunders R; O'Neill S; Kalinga A
Acta Trop; 2018 May; 181():50-59. PubMed ID: 29410302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]